Rani Therapeutics Inc.

1.46
-0.07 (-4.58%)
At close: Mar 03, 2025, 3:59 PM
1.55
6.16%
After-hours: Mar 03, 2025, 07:00 PM EST

Rani Therapeutics Balance Sheet Statement

Year FY23 FY22 FY21 FY20 FY19
Cash & Equivalents 5.86M 27.01M 117.45M 73.06M 16.54M
Short-Term Investments 42.67M 71.47M n/a n/a n/a
Long-Term Investments n/a n/a n/a n/a 1.63M
Other Long-Term Assets 246K n/a n/a n/a n/a
Receivables n/a n/a n/a 1.72M 250K
Inventory n/a n/a n/a n/a 1.00
Other Current Assets 2.31M 2.44M 2.14M 167K 158K
Total Current Assets 50.85M 100.92M 119.59M 74.94M 16.94M
Property-Plant & Equipment 6.82M 7.1M 4.61M 4.47M 4.45M
Goodwill & Intangibles n/a n/a n/a n/a n/a
Total Long-Term Assets 7.07M 7.1M 4.61M 4.47M 6.08M
Total Assets 57.92M 108.03M 124.21M 79.42M 23.02M
Account Payables 648K 1.46M 1.08M 537K 198K
Deferred Revenue 1.21M n/a n/a 2.72M 179K
Short-Term Debt 5.62M 2.01M n/a 1.36M n/a
Other Current Liabilities 1.73M 1.34M 1.56M 695K 3.12M
Total Current Liabilities 7.99M 4.82M 2.64M 5.31M 3.5M
Long-Term Debt 24.48M 29.21M n/a 2.41M 115.5M
Other Long-Term Liabilities n/a n/a n/a 185.03M 655K
Total Long-Term Liabilities 24.48M 29.21M n/a 187.45M 116.16M
Total Liabilities 32.47M 34.02M 2.64M 192.75M 119.66M
Total Debt 30.1M 30.21M n/a 3.77M 115.5M
Common Stock 5K 5K 5K 664K 664K
Retained Earnings -72.89M -38.92M -8.33M -114M -97.3M
Comprehensive Income -12K -73K -124.21M -849.03K -780.16K
Shareholders Equity 12.87M 36.85M 47.41M -113.34M -96.64M
Total Investments 42.67M 71.47M n/a n/a 1.63M